Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aspen Pharmacare Holdings Ltd gives H1 2014 earnings outlook


Friday, 21 Feb 2014 09:50am EST 

Aspen Pharmacare Holdings Ltd:Expects H1 2014 diluted normalised headline earnings per share (DNHEPS) from continuing operations in the range of 20-24 pct.Expects H1 2014 headline earnings per share in the range of 12-16 pct.Expects H1 2014 earnings per share in the range of 12-16 pct.